DK3247711T3 - Hidtil ukendte salte og polymorfer af scy-078 - Google Patents
Hidtil ukendte salte og polymorfer af scy-078 Download PDFInfo
- Publication number
- DK3247711T3 DK3247711T3 DK16703009.7T DK16703009T DK3247711T3 DK 3247711 T3 DK3247711 T3 DK 3247711T3 DK 16703009 T DK16703009 T DK 16703009T DK 3247711 T3 DK3247711 T3 DK 3247711T3
- Authority
- DK
- Denmark
- Prior art keywords
- polymorphes
- scy
- still unknown
- salts
- unknown salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2015/070967 | 2015-01-19 | ||
| PCT/US2016/013356 WO2016118396A1 (en) | 2015-01-19 | 2016-01-14 | Novel salts and polymorphs of scy-078 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3247711T3 true DK3247711T3 (da) | 2022-05-09 |
Family
ID=55300785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16703009.7T DK3247711T3 (da) | 2015-01-19 | 2016-01-14 | Hidtil ukendte salte og polymorfer af scy-078 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US10174074B2 (da) |
| EP (2) | EP4039684A1 (da) |
| DK (1) | DK3247711T3 (da) |
| EA (1) | EA036874B1 (da) |
| ES (1) | ES2913111T3 (da) |
| HK (1) | HK1247196A1 (da) |
| HR (1) | HRP20220544T1 (da) |
| HU (1) | HUE058721T2 (da) |
| LT (1) | LT3247711T (da) |
| PL (1) | PL3247711T3 (da) |
| PT (1) | PT3247711T (da) |
| RS (1) | RS63234B1 (da) |
| SI (1) | SI3247711T1 (da) |
| WO (1) | WO2016118396A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10174074B2 (en) | 2015-01-19 | 2019-01-08 | Scynexis, Inc. | Salts and polymorphs of SCY-078 |
| MA49889A (fr) | 2017-04-10 | 2020-06-24 | Scynexis Inc | Agents antifongiques utilisés en association |
| FI3661503T3 (fi) | 2017-08-04 | 2022-12-15 | PARANTUNEEN AKTIIVISUUDEN HAPPAMASSA pH:SSA OMAAVIA SIENILÄÄKKEITÄ | |
| SG11202006313WA (en) * | 2018-01-02 | 2020-07-29 | Scynexis Inc | Injectable compositions of triterpenoid antifungals encapsulated in liposomes |
| WO2021092349A1 (en) | 2019-11-08 | 2021-05-14 | Scynexis, Inc. | Lipid-based formulations of scy-078 salts |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010019204A1 (en) * | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Antifungal agents |
| EP2326172B1 (en) * | 2008-08-12 | 2014-10-22 | Scynexis, Inc. | Antifungal agents |
| US10174074B2 (en) | 2015-01-19 | 2019-01-08 | Scynexis, Inc. | Salts and polymorphs of SCY-078 |
-
2016
- 2016-01-14 US US14/995,593 patent/US10174074B2/en active Active
- 2016-01-14 LT LTEPPCT/US2016/013356T patent/LT3247711T/lt unknown
- 2016-01-14 EA EA201791645A patent/EA036874B1/ru unknown
- 2016-01-14 ES ES16703009T patent/ES2913111T3/es active Active
- 2016-01-14 DK DK16703009.7T patent/DK3247711T3/da active
- 2016-01-14 SI SI201631524T patent/SI3247711T1/sl unknown
- 2016-01-14 HR HRP20220544TT patent/HRP20220544T1/hr unknown
- 2016-01-14 PT PT167030097T patent/PT3247711T/pt unknown
- 2016-01-14 EP EP22160937.3A patent/EP4039684A1/en active Pending
- 2016-01-14 EP EP16703009.7A patent/EP3247711B1/en active Active
- 2016-01-14 RS RS20220415A patent/RS63234B1/sr unknown
- 2016-01-14 HU HUE16703009A patent/HUE058721T2/hu unknown
- 2016-01-14 WO PCT/US2016/013356 patent/WO2016118396A1/en active Application Filing
- 2016-01-14 PL PL16703009T patent/PL3247711T3/pl unknown
-
2018
- 2018-05-23 HK HK18106647.4A patent/HK1247196A1/zh unknown
- 2018-11-28 US US16/203,273 patent/US10370406B2/en active Active
-
2019
- 2019-06-11 US US16/437,693 patent/US10927142B2/en active Active
-
2021
- 2021-01-29 US US17/161,920 patent/US20210395296A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US10174074B2 (en) | 2019-01-08 |
| EA201791645A1 (ru) | 2018-01-31 |
| PL3247711T3 (pl) | 2022-06-27 |
| US10370406B2 (en) | 2019-08-06 |
| EP4039684A1 (en) | 2022-08-10 |
| LT3247711T (lt) | 2022-05-25 |
| EP3247711B1 (en) | 2022-03-09 |
| PT3247711T (pt) | 2022-05-16 |
| US20190359648A1 (en) | 2019-11-28 |
| RS63234B1 (sr) | 2022-06-30 |
| ES2913111T3 (es) | 2022-05-31 |
| US20190153024A1 (en) | 2019-05-23 |
| US10927142B2 (en) | 2021-02-23 |
| HRP20220544T1 (hr) | 2022-08-05 |
| EA036874B1 (ru) | 2020-12-30 |
| HUE058721T2 (hu) | 2022-09-28 |
| EP3247711A1 (en) | 2017-11-29 |
| SI3247711T1 (sl) | 2022-07-29 |
| HK1247196A1 (zh) | 2018-09-21 |
| US20210395296A1 (en) | 2021-12-23 |
| WO2016118396A1 (en) | 2016-07-28 |
| US20160207956A1 (en) | 2016-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3371171T3 (da) | Inhibitorer af RET | |
| DK3368069T3 (da) | Anvendelse af myostatininhibitorer og kombinationsterapier | |
| DK3259253T3 (da) | Sulfonylureaer og relaterede forbindelser og brug af samme | |
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| DK3377059T3 (da) | Hæmmere af cxcr2 | |
| DK3851537T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3423451T3 (da) | Inhibitorer af wdr5-protein-proteinbinding | |
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3262046T3 (da) | Salte af pi3k-inhibitor og fremgangsmåder til fremstilling deraf | |
| DK3185868T3 (da) | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| DK3442972T3 (da) | Bromdomænehæmmere | |
| DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3288553T3 (da) | Kombinationer af cannabinoider og n-acylethanolaminer | |
| DK3429998T3 (da) | Fremgangsmåde til fremstilling af quinolin-2-yl-phenylaminderivater og disses salte | |
| DK3215493T3 (da) | Syntese af copanlisib og dihydrochloridsalt deraf | |
| DK3457851T3 (da) | Derivater af sobetirom | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| DK3365323T3 (da) | Salte af tetracycliner | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3506904T3 (da) | Behandling af demens | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK3390422T3 (da) | Krystalformer af lnt | |
| DK3347342T3 (da) | Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner | |
| DK3265126T3 (da) | Kombinationsformulering af tesofensin og metoprolol |